Phosphate prodrugs of PD154075

Area of Science:

• Medicinal Chemistry
• Drug Development
• Organic Synthesis

Background:

• PD154075 is a compound requiring prodrug strategies for improved delivery.
• Phosphate prodrugs are a common approach to enhance drug properties.
• The indole moiety of PD154075 presents challenges for prodrug linkage.

Purpose of the Study:

• To explore strategies for creating phosphate prodrugs of PD154075.
• To identify a linker that improves the aqueous solubility and stability of PD154075 prodrugs.
• To evaluate the in vivo bio-reconversion of the developed prodrug.

Main Methods:

• Synthesis of various phosphate prodrugs of PD154075.
• Investigation of different linking strategies for phosphate group attachment.
• Characterization of compound 9, a novel phosphate prodrug of PD154075, including solubility and stability assessments.
• In vivo studies to assess bio-reconversion.

Main Results:

• Several linking strategies were explored for PD154075 phosphate prodrug preparation.
• A novel linker, p-hydroxymethylbenzoyloxymethoxycarbonyl, was identified.
• Compound 9, utilizing this novel linker, demonstrated significantly increased aqueous solubility.
• Compound 9 exhibited sufficient stability in aqueous solution.
• Good bio-reconversion of compound 9 in vivo was observed.

Conclusions:

• The novel p-hydroxymethylbenzoyloxymethoxycarbonyl linker effectively creates a PD154075 phosphate prodrug (compound 9).
• Compound 9 possesses enhanced aqueous solubility and stability, crucial for pharmaceutical applications.
• The prodrug demonstrates promising bio-reconversion, indicating potential for improved therapeutic efficacy.